Efonidipine Hydrochloride Monoethanolate is a dihydropyridine calcium channel blocker utilized primarily in the treatment of hypertension. By simultaneously blocking both L-type and T-type calcium channels,… Read more
Efonidipine Hydrochloride Monoethanolate is a dihydropyridine calcium channel blocker utilized primarily in the treatment of hypertension. By simultaneously blocking both L-type and T-type calcium channels, this agent helps to reduce vascular resistance, increase coronary blood flow, and prevent cardiac hypertrophy and remodeling to attenuate myocardial ischemia. This category provides access to high-quality reference standards of the active pharmaceutical ingredient, along with related impurities and stable isotope labelled compounds. These materials are vital for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and ongoing quality control. Utilizing accurate standards for the drug substance and its degradation products ensures precision in analytical testing, supporting the maintenance of regulatory compliance and product safety throughout the drug development and manufacturing lifecycle.